Cargando…
Nanoparticle-based drug delivery systems: What can they really do in vivo?
In the past few decades, there has been explosive growth in the construction of nanoparticle-based drug delivery systems (NDDSs), namely nanomedicines, owing to their unique properties compared with traditional drug formulations. However, because of a variety of challenges, few nanomedicines are on...
Autores principales: | Wang, Yi-Feng, Liu, Lu, Xue, Xue, Liang, Xing-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461891/ https://www.ncbi.nlm.nih.gov/pubmed/28620465 http://dx.doi.org/10.12688/f1000research.9690.1 |
Ejemplares similares
-
What Does PLIER Really Do?
por: Therneau, Terry M., et al.
Publicado: (2008) -
Preoperative anxiety: what are we really doing?
por: Buonanno, Pasquale, et al.
Publicado: (2021) -
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
por: Pinheiro, Rúben G. R., et al.
Publicado: (2021) -
What Do Microglia Really Do in Healthy Adult Brain?
por: Augusto-Oliveira, Marcus, et al.
Publicado: (2019) -
Cosolvents in Self-Emulsifying Drug Delivery Systems
(SEDDS): Do They Really Solve Our Solubility Problems?
por: Jörgensen, Arne Matteo, et al.
Publicado: (2020)